Curis Lifesciences Limited is a pharmaceutical manufacturer engaged in producing a wide range of tablets, capsules, oral liquids, ointments, sterile ophthalmic ointments, and external preparations. The company operates under three verticals — Loan License Manufacturing, Contract Manufacturing, and Direct Exports, catering to both domestic and international markets across over 35 countries, including the UK, Kenya, Nigeria, and Vietnam.

Curis Lifesciences Limited, an Book Built Issue, amounting to â‚¹ 27.52 Crore, consisting entirely an entirely a fresh issue of 0.22 crore shares of â‚¹ 27.52 crore The subscription period for the  Curis Lifesciences IPO opens on November 07, 2025, and closes on November 11, 2025. The allotment is expected to be finalized on or about Wednesday, November 12, 2025, and the shares will be listed on the NSE SME with a tentative listing date set on or about Friday, November 14, 2025.

The Share Price Band of Curis Lifesciences IPO is set at â‚¹ 120 to ₹ 128 per equity share. The Market Capitalisation of the Curis Lifesciences at IPO price of ₹ 128 per equity share will be  â‚¹ 103.48 Crores. The lot size of the IPO is 1,000 shares. Retail investors are required to invest a minimum of  â‚¹ 256,000 (2,000 shares), while the minimum investment for High-Net-Worth Individuals (HNIs) is 3 lots (3,000 shares), amounting to â‚¹ 384,000.

Finaax Capital Advisors Private Limited are the book running lead manager of the Curis Lifesciences, while MUFG Intime India Pvt.Ltd. is the registrar for the issue. The Market Maker of the company is RS Wealth Management Private Limited.

Curis Lifesciences Limited IPO GMP Today
The Grey Market Premium of Curis Lifesciences IPO is expected to be â‚¹ 0 based on the financial performance of the company. No real trading is done on the basis of Grey Market Premium that's why no real discovery of price can be done before the listing of shares on the stock exchange. The Grey Market Premium totally depends upon the Demand and Supply of the shares of the company in unorganized manner which is not recommended. The Grey Market Premium is mentioned for educational and informational purposes only.

Curis Lifesciences Limited IPO Live Subscription Status Today: Real-Time Update

As of 06:35 PM on 11 November, 2025, the Curis Lifesciences IPO live subscription status shows that the IPO subscribed 49.63 times on its Final Day of subscription period. Check the Curis Lifesciences  IPO Live Subscription Status Today at NSE.

Curis Lifesciences Limited IPO Allotment Date - Step by Step Guide to Check Allotment Status Online
Curis Lifesciences  IPO allotment date is 12 November, 2025, Wednesday. Curis Lifesciences IPO Allotment will be out on 12 November, 2025, Wednesday and will be live on Registrar Website from the allotment date.
Check MUFG Intime India Pvt.Ltd. IPO Allotment Status here. Here's how you can check the allotment status:
- Navigate to the IPO allotment status page.
- Select Curis Lifesciences Limited IPO from the dropdown list of IPOs
- Enter your application number, PAN, or DP Client ID
- Submit the details to check your allotment status.
By following either of these methods, investors can quickly determine their allotment status and proceed accordingly with their investments.

Objectives of Curis Lifesciences Limited IPO
Curis Lifesciences to utilise the Net Proceeds towards the following objects: 
1. â‚¹ 244.27 Lakhs is required for Capital Expenditure towards Upgradation/Improvement of our existing Manufacturing Facilities.
2. â‚¹ 361.99 Lakhs is required for Capital Expenditure towards Construction of a Storage Facility.
3. â‚¹ 186.45 Lakhs is required for Pre-payment / Repayment of outstanding Secured Loans.
4. â‚¹ 269.30 Lakhs is required for Product Registrations in other countries.
5  â‚¹ 1,125.00 Lakhs is required for Funding our Working Capital Requirements
6. Balance for General corporate purposes.

Refer to Curis Lifesciences Limited RHP for more details about the Company.